On June 22, 2015, the U.S. Department of Health and Human Services (HHS) announced that it had eliminated the redundant Public Health Service (PHS) review process for federally regulated marijuana research, …
Medical Marijuana Research Month is a chance for customers at dispensaries and marijuana retail stores nationwide to make a donation during the month of November to support MAPS’ research on whole …
On September 22, 2014, U.S. Department of Health and Human Services Secretary Sylvia M. Burwell formally rejected a request from 30 members of Congress requesting that HHS end the obstructive Public Health …
On April 28, 2012, the results of a recently completed exploratory study of medical marijuana in veterans with PTSD were presented (slides available here in PDF format) by Dr. Mordechai Mashiah, Deputy …
MAPS has received a generous offer for pro-bono legal representation from the Washington, DC law firm Covington & Burling LLP, one of the foremost law firms representing the pharmaceutical industry, …
MAPS hosted the Denver Mile High Marijuana Summit, which featured leading experts about marijuana policy: MAPS Executive Director Rick Doblin, Ph.D., Ethan Nadelmann, Executive Director, Drug Policy Alliance, …
MAPS signed a contract with The Raben Group, a Washington, D.C., lobbying group. The Raben Group will initially review and analyze the political situation relating to the Craker case, then provide MAPS …
On Sept. 22, MAPS signed a contract with The Raben Group, a Washington, D.C., lobbying group. The Raben Group will analyze the political situation related to the Craker case and then provide MAPS with …
MAPS has hired Chris Chiles and Stephen Morseman to coordinate a campaign to obtain a DEA license for Professor Lyle Craker of UMass Amherst to grow marijuana under contract to MAPS, and end the National …
This is an excellent expose about Dr. Mahmoud Elsohly’s NIDA sponsored marijuana production facility at the University of Mississippi. The article discusses the federal government’s blocking …
At present, the National Institute on Drug Abuse (NIDA) has a monopoly on the supply of marijuana that can be used in research, seriously hindering medical marijuana research. NIDA provides inferior, low-potency …
Oregon Board of Pharmacy 800 NE Oregon St., Suite 150 Portland, OR 97232-2162 News Release For Immediate Release Contact: Paige Clark, …
